Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis
- PMID: 25854964
- PMCID: PMC4390726
- DOI: 10.1136/bmjopen-2014-006404
Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis
Abstract
Objective: Increasing evidence suggests that cancer-associated inflammation is associated with poor prognosis in patients with cancer. The role of the neutrophil-lymphocyte ratio (NLR) as a predictor in renal cell carcinoma (RCC) remains controversial. We conducted the meta-analysis to determine the association between NLR and clinical outcome of patients with RCC.
Methods and materials: Studies were identified from PubMed and EMBASE databases in March 2014. Meta-analysis was performed to generate combined HRs with 95% CIs for overall survival (OS) and recurrence-free/progress-free survival (RFS/PFS).
Results: 15 cohorts containing 3357 patients were included. Our analysis results indicated that elevated NLR predicted poorer OS (HR=1.82, 95% CI 1.51 to 2.19) and RFS/PFS (HR=2.18, 95% CI 1.75 to 2.71) in patients with RCC. These findings were robust when stratified by study region, sample size, therapeutic intervention, types of RCC and study quality. However, it differed significantly by assessment of the cut-off value defining 'elevated NLR' in RFS/PFS (p=0.004). The heterogeneity in our meta-analysis was mild to moderate.
Conclusions: Elevated NLR indicates a poorer prognosis for patients with RCC. NLR should be monitored in patients with RCC for rational risk stratification and treatment individualisation.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Figures




Similar articles
-
Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.BMC Urol. 2020 Jul 6;20(1):90. doi: 10.1186/s12894-020-00665-8. BMC Urol. 2020. PMID: 32631294 Free PMC article.
-
Elevated neutrophil-lymphocyte ratio combined with hyponatremia indicate poor prognosis in renal cell carcinoma.Acta Oncol. 2020 Jan;59(1):13-19. doi: 10.1080/0284186X.2019.1654128. Epub 2019 Aug 26. Acta Oncol. 2020. PMID: 31448981
-
Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.Oncotarget. 2016 Jul 12;7(28):44039-44046. doi: 10.18632/oncotarget.9836. Oncotarget. 2016. PMID: 27270655 Free PMC article.
-
Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.Urol Oncol. 2016 May;34(5):239.e9-15. doi: 10.1016/j.urolonc.2015.12.006. Epub 2016 Jan 21. Urol Oncol. 2016. PMID: 26803433
-
Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.Immunotherapy. 2019 May;11(7):631-643. doi: 10.2217/imt-2018-0175. Immunotherapy. 2019. PMID: 30943858
Cited by
-
Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma.Explor Target Antitumor Ther. 2024;5(6):1199-1222. doi: 10.37349/etat.2024.00271. Epub 2024 Sep 20. Explor Target Antitumor Ther. 2024. PMID: 39465007 Free PMC article. Review.
-
Citrullinated Histone H3, a Marker for Neutrophil Extracellular Traps, Is Associated with Poor Prognosis in Cutaneous Squamous Cell Carcinoma Developing in Patients with Recessive Dystrophic Epidermolysis Bullosa.Cancers (Basel). 2024 Jul 6;16(13):2476. doi: 10.3390/cancers16132476. Cancers (Basel). 2024. PMID: 39001538 Free PMC article.
-
Neutrophil-to-lymphocyte ratio correlates with prognosis and response to chemotherapy in patients with non-M3 de novo acute myeloid leukemia.Transl Cancer Res. 2021 Feb;10(2):1013-1024. doi: 10.21037/tcr-20-2179. Transl Cancer Res. 2021. PMID: 35116428 Free PMC article.
-
Association of neutrophil-to-lymphocyte ratio and natural killer cell activity revealed by measurement of interferon-gamma levels in a healthy population.J Clin Lab Anal. 2019 Jan;33(1):e22640. doi: 10.1002/jcla.22640. Epub 2018 Aug 13. J Clin Lab Anal. 2019. PMID: 30105845 Free PMC article.
-
The immunosuppressive phenotype of tumor-infiltrating neutrophils is associated with obesity in kidney cancer patients.Oncoimmunology. 2020 Apr 5;9(1):1747731. doi: 10.1080/2162402X.2020.1747731. eCollection 2020. Oncoimmunology. 2020. PMID: 32313729 Free PMC article.
References
-
- MacDonald N. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care. J Support Oncol 2007;5:157–62; discussion 164–156, 183. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical